Effect of the 13-valent pneumococcal conjugate vaccine on invasive …

Articles citing Effect of the 13-valent pneumococcal conjugate vaccine on invasive …

Title / Author	Year
Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000–17: a prospective national observational cohort study SN Ladhani, S Collins, A Djennad, CL Sheppard, R Borrow, NK Fry, ... The Lancet Infectious Diseases 18 (4), 441-451	2018
Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000–15 B Wahl, KL O'Brien, A Greenbaum, A Majumder, L Liu, Y Chu, I Lukšić, ... The Lancet Global Health 6 (7), e744-e757	2018
Serotype distribution of Streptococcus pneumoniae causing invasive disease in children in the post-PCV era: A systematic review and meta-analysis E Balsells, L Guillot, H Nair, MH Kyaw PloS one 12 (5), e0177113	2017
Acute bacterial meningitis in adults F McGill, RS Heyderman, S Panagiotou, AR Tunkel, T Solomon The Lancet 388 (10063), 3036-3047	2016
Effectiveness of 13-valent pneumococcal conjugate vaccine for prevention of invasive pneumococcal disease in children in the USA: a matched case-control study MR Moore, R Link-Gelles, W Schaffner, R Lynfield, C Holtzman, ... The Lancet Respiratory Medicine 4 (5), 399-406	2016
Effects of PCV7 and PCV13 on invasive pneumococcal disease and carriage in Stockholm, Sweden I Galanis, A Lindstrand, J Darenberg, S Browall, P Nannapaneni, ... European Respiratory Journal 47 (4), 1208-1218	2016
Effect of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease in The Gambia: a population-based surveillance study GA Mackenzie, PC Hill, DJ Jeffries, I Hossain, U Uchendu, D Ameh, ... The Lancet infectious diseases 16 (6), 703-711	2016
Effectiveness of the 23-valent pneumococcal polysaccharide vaccine (PPV23) against pneumococcal disease in the elderly: systematic review and meta-analysis G Falkenhorst, C Remschmidt, T Harder, E Hummers-Pradier, ... PLoS One 12 (1), e0169368	2017
Indirect effects of childhood pneumococcal conjugate vaccination on invasive pneumococcal disease: a systematic review and meta-analysis T Shiri, S Datta, J Madan, A Tsertsvadze, P Royle, MJ Keeling, ... The Lancet Global Health 5 (1), e51-e59	2017
Invasive pneumococcal disease among immunocompromised persons: implications for vaccination programs A Shigayeva, W Rudnick, K Green, DK Chen, W Demczuk, WL Gold, ... Clinical Infectious Diseases 62 (2), 139-147	2016
Comparison of the impact of pneumococcal conjugate vaccine 10 or pneumococcal conjugate vaccine 13 on invasive pneumococcal disease in equivalent populations P Naucler, I Galanis, E Morfeldt, J Darenberg, Å Örtqvist, ... Clinical Infectious Diseases 65 (11), 1780-1790. e1	2017
Pneumococcal serotype evolution in Western Europe MTT Htar, D Christopoulou, HJ Schmitt BMC infectious diseases 15 (1), 419	2015
Whole genome sequencing of Streptococcus pneumoniae: development, evaluation and verification of targets for serogroup and serotype prediction using an automated pipeline G Kapatai, CL Sheppard, A Al-Shahib, DJ Litt, AP Underwood, ... PeerJ 4, e2477	2016
Cause-specific mortality for 249 causes in Brazil and states during 1990–2015: a systematic analysis for the global burden of disease study 2015 EB Franca, VM de Azeredo Passos, DC Malta, BB Duncan, ALP Ribeiro, ... Population health metrics 15 (1), 1-17	2017
Invasive disease potential of pneumococci before and after the 13-valent pneumococcal conjugate vaccine implementation in children E Varon, R Cohen, S Béchet, C Doit, C Levy Vaccine 33 (46), 6178-6185	2015
Streptococcus pneumoniae serotype 19A: worldwide epidemiology R Isturiz, HL Sings, B Hilton, A Arguedas, RR Reinert, L Jodar Expert review of vaccines 16 (10), 1007-1027	2017
Serotypes, antimicrobial susceptibility, and molecular epidemiology of invasive and non-invasive Streptococcus pneumoniae isolates in paediatric patients after the introduction of 13-valent conjugate vaccine in a nationwide surveillance study conducted in Japan in 2012–2014 S Nakano, T Fujisawa, Y Ito, B Chang, S Suga, T Noguchi, M Yamamoto, ... Vaccine 34 (1), 67-76	2016
Measurements of ψ (2 S) and X (3872)→ J/ψ π+ π− production in pp collisions at $$\sqrt {s}= 8$$ TeV with the ATLA S detector M Aaboud, G Aad, B Abbott, J Abdallah, B Abeloos, R Aben, OS AbouZeid, ... Journal of High Energy Physics 2017 (1), 117	2017
Pneumococcal conjugate vaccine 13 delivered as one primary and one booster dose (1+ 1) compared with two primary doses and a booster (2+ 1) in UK infants: a multicentre, parallel group randomised controlled trial D Goldblatt, J Southern, NJ Andrews, P Burbidge, J Partington, L Roalfe, ... The Lancet Infectious Diseases 18 (2), 171-179	2018
Interim results of an ecological experiment—Conjugate vaccination against the pneumococcus and serotype replacement WP Hausdorff, WP Hanage Human vaccines & immunotherapeutics 12 (2), 358-374	2016

1 - 20

Dates and citation counts are estimated and are determined automatically by a computer program.